|
| |
adherex bioorg med chem Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Amination
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd, 760 Morooka-cho,, Bioorg Med Chem. 2008 Dec 1;16(23):10129-56. Epub 2008 Sep 25. ...
http://www.bioportfolio.com/indepth/Amination.html...
|
Disrupting Tumour Blood Vessels
Bioorg. Med. Chem. Lett. 11, 51-54 (2001); Hadimani, M. B. et al. ... Bioorg. Med. Chem. Lett. 13, 1505-1508 (2003). Liou, J. P. et al. ...
http://www.medscape.com/viewarticle/506711_8...
|
Disrupting tumour blood vessels : Article : Nature Reviews Cancer
The peptide N-cadherin inhibitor known as Exherin, developed by Adherex, is in Phase I clinical trials ..... Bioorg. Med. Chem. Lett. 13, 1505–1508 (2003). ...
http://www.nature.com/nrc/journal/v5/n6/full/nrc1628.html...
|
|
